| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2557 | Hjc05100 | Novel apigenin analogue, suppressing pancreatic stellate cell proliferation |
|
| DCC2558 | Hk Inhibitor 2 | Novel inhibitor of YycG histidine kinase (HK), showing potent antibiofim activity against Staphylococcus epidermidis |
|
| DCC2559 | Hk2 Modulator-1 | Novel allosteric hexokinase 2 (HK2) modulator, selectively detaching HK2 from the mitochondria |
|
| DCC2560 | hl010183 | Novel Metformin Derivative; Inhibitor of Proliferation and Invasion of Triple-Negative Breast Cancer Cells |
|
| DCC2561 | Hl-3-68 | Novel SARS-CoV-2 Main Protease (Mpro) inhibitor, binding to Subsites S1 and S2 (K d =0.69 µM) |
|
| DCC2562 | hla20a | Selective Acetylcholinesterase Inhibitor |
|
| DCC2563 | Hlb-0532247 | Novel phosphoramidate prodrug of ddhCTP, effectively reducing titers of Zika and West Nile viruses in cell culture with minimal nonspecific toxicity to host cells |
|
| DCC2564 | Hlcl-61 | First-in-class inhibitor of protein arginine methyltransferase 5 (PRMT5) |
|
| DCC2565 | Hlö-7 Dimesylate | Novel Nerve Agent Reactivator |
|
| DCC2566 | Hm-50316 | Potent and highly selective FABP4 inhibitor |
|
| DCC2567 | Hm90822 | Novel antagonist to the inhibitors of apoptosis (IAPs), potentiating cell death in EGFR-overexpressing non-small-cell lung cancer cells |
|
| DCC2568 | Hmao-b Inhibitor 5 | Novel highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action (IC 50 = 42 nM; SI > 2375) |
|
| DCC2569 | Hmbpp Triammonium Salt | Potent stimulator of gamma delta T cells |
|
| DCC2570 | Hmi-1a3 | Protein kinase C partial agonist, targeting the C1 domain, inhibiting cell proliferation, decreasing cell viability and inducing an apoptotic response |
|
| DCC2571 | Hmk-32 | Irriversible inhibitor of GSK3 |
|
| DCC2572 | Hm-mc4-ppea | Potent inhibitor of nicotinamide phosphoribosyltransferase (Nampt) |
|
| DCC2573 | Hmr1031 | Potent and specific integrin α4ß1 or very late antigen 4 (VLA-4) receptor antagonist, binding to vascular cell adhesion molecule-1 (VCAM-1) and fibronectin |
|
| DCC2574 | Hmr1426 | Novel food intake-reducing agent |
|
| DCC2575 | Hmr-1566 | Potent and selective I ks channel blocker |
|
| DCC2576 | Hmref-s-neu5ac | Novel sialidase-activatable fluorescence probe with improved stability for the sensitive detection of sialidase |
|
| DCC2577 | Hmref-ßglcnac | Novel Hexosaminidase-Targeting Fluorescence Probe for Visualizing Human Colorectal Cancer. |
|
| DCC2578 | Hms-i1 | Novel chemical probe for heterochromatin formation and function, disrupting of heterochromatin-mediated transcriptional gene silencing |
|
| DCC2579 | Hms-i2 | Novel chemical probe for heterochromatin formation and function, disrupting of heterochromatin-mediated transcriptional gene silencing |
|
| DCC2580 | Hmsir-tubulin | Novel Blinking Fluorescent Probe for Tubulin Nanoscopy in Living and Fixed Cells |
|
| DCC2581 | Hn-cbl | Novel selective inhibitor of the lymphocytic leukemia (LL) cell survival , Selectively Enhancing the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo |
|
| DCC2582 | Hnpc-a3066 | Novel strobilurin acaricide, exhibiting larvicidal and ovicidal activities against various acarids |
|
| DCC2583 | Hocpca | Highly potent and selective ligand for the GHB binding sites, binding with 27 times better affinity than GHB itself and acrossing the blood brain barrier in vitro and in vivo |
|
| DCC2584 | Hoechst-3325 | Fluorescent indicator of apoptosis, binding the minor groove of DNA at A and T rich regions |
|
| DCC2585 | Hoi-07 | Novel specific Aurora B inhibitor |
|
| DCC2586 | Holomycin | Antibiotic |
|
